Archives
Merck's Anti-Clot Drug 'Zontivity' Gets FDA Approval
Merck's clot preventer drug, Zontivity or vorapaxar, is now approved by the U.S Food and Drug Administration.
Latest Research Articles
GaitTrack App Turns Cellphone into Medical Monitor for Heart and Lungs
Antibiotic Resistant Germs Have Us Surrounded, Literally
New 'Soul-Sucking' Wasp Species Named after 'Harry Potter' Dementors
Smartwear Shirt Tracks Your Athletic Performance
Guzzling Energy Drinks Linked to Other Bad Behavior
Tick Populations Remain High Despite Long Winter
Pesticides Toxic to Shrimp and Snails, Scientists Gain New Insight
Centenarians Reveal Genetic Key to Longevity
ED Drugs May Treat Muscular Dystrophy
West Coast Kelp Safe from Fukushima-Related Radiation (VIDEO)
Plants to Grow on Mars by 2021
NASA Spots Solar Flare Dancing on Sun's Surface (VIDEO)
MOST POPULAR
-
Met Office Issues Warning About Thunderstorms And Flooding: Are They Coming To A Place Near You?
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
-
Enjoying Nature: How Outdoor Activities Can Benefit Children & Teens
-
Texas Woman Hopped on a Kayak to Escape Floodwaters With Her Dogs: 'I'm Still in Shock'
